Clinical Trials Browser

Phase 2 × Suspended × lenvatinib × Clear all

NCT03139747 2021-10-15

UPCC 36315 A Phase II Study Of Everolimus (RAD001) And Lenvatinib (E7080) In Patients With Metastatic Differentiated Thyroid Cancer Who Have Progressed on Lenvatinib Alone

Phase 2 Suspended

Thyroid Neoplasms

NCT03779100 2019-01-28

Lenvatinib Plus PD-1 Antibody for Unresectable ICC

Phase 2 Suspended

Gastrointestinal

Cholangiocarcinoma